ADARx Pharmaceuticals, Inc. (ADRX)
17.63
-0.05
(-0.28%)
USD |
NASDAQ |
Oct 23, 16:00
17.80
+0.17
(+0.96%)
After-Hours: 20:00
ADARx Pharmaceuticals Price : 17.63 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 17.68 | 18.32 | 17.00 | 17.63 | 177568.0 |
| Oct 22, 2026 | 17.18 | 17.88 | 17.18 | 17.68 | 181463.0 |
| Oct 21, 2026 | 17.58 | 18.17 | 17.00 | 17.13 | 441573.0 |
| Oct 20, 2026 | 17.98 | 18.55 | 16.61 | 17.68 | 1.075M |
| Oct 19, 2026 | 17.76 | 18.32 | 17.05 | 17.63 | 262029.0 |
| Oct 16, 2026 | 17.73 | 18.60 | 17.50 | 17.65 | 247130.0 |
| Oct 15, 2026 | 17.75 | 18.32 | 17.50 | 17.70 | 283371.0 |
| Oct 14, 2026 | 17.72 | 18.28 | 17.31 | 17.83 | 285475.0 |
| Oct 13, 2026 | 18.00 | 18.82 | 17.57 | 17.70 | 220986.0 |
| Oct 12, 2026 | 17.78 | 18.75 | 17.57 | 17.97 | 350766.0 |
| Oct 09, 2026 | 17.70 | 18.19 | 17.06 | 17.78 | 688460.0 |
| Oct 08, 2026 | 17.13 | 18.10 | 16.64 | 17.68 | 420188.0 |
| Oct 07, 2026 | 18.33 | 18.70 | 17.20 | 17.33 | 705703.0 |
| Oct 06, 2026 | 19.05 | 19.56 | 18.01 | 18.58 | 1.035M |
| Oct 05, 2026 | 18.25 | 19.40 | 17.30 | 19.05 | 913953.0 |
| Oct 02, 2026 | 19.31 | 19.53 | 17.84 | 18.25 | 937067.0 |
| Oct 01, 2026 | 19.99 | 20.77 | 18.99 | 19.54 | 962225.0 |
| Sep 30, 2026 | 20.65 | 21.61 | 19.23 | 19.94 | 788842.0 |
| Sep 29, 2026 | 19.90 | 21.50 | 19.51 | 20.64 | 1.299M |
| Sep 28, 2026 | 19.00 | 21.77 | 18.50 | 20.09 | 1.205M |
| Sep 25, 2026 | 22.10 | 23.21 | 19.00 | 19.35 | 4.214M |
| Sep 24, 2026 | 17.00 | 17.00 | 17.00 | 17.00 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| PS Ratio | 608.57 |
| Price to Free Cash Flow | 7.564 |
| Earnings Yield | -4.36% |
| Market Cap | 1.883B |